Literature DB >> 7559603

Syp associates with gp130 and Janus kinase 2 in response to interleukin-11 in 3T3-L1 mouse preadipocytes.

D K Fuhrer1, G S Feng, Y C Yang.   

Abstract

Protein tyrosine phosphorylation and thus dephosphorylation are part of the interleukin (IL)-11 response in mouse 3T3-L1 cells. We report here for the first time the involvement and interactions of the SH2-containing protein tyrosine phosphatase Syp in the IL-11 signal transduction pathway. Addition of IL-11 to 3T3-L1 cells resulted in an increase in the tyrosine phosphorylation of Syp. When cell lysates were precipitated with glutathione S-transferase fusion products of Syp, the C-terminal SH2 domain of Syp was shown to precipitate several proteins of 70, 130, 150, and 200 kDa that were tyrosine phosphorylated in response to IL-11. Reciprocal immunoprecipitation experiments showed that Syp was inducibly associated with both gp130 and Janus kinase 2 (JAK2). A phosphopeptide containing the sequence for a potential Syp binding site (YXXV) was used to compete with the associations of Syp with gp130 and JAK2. The phosphopeptide reduced the Syp association with both gp130 and JAK2. To summarize, Syp has multiple interactions in IL-11 signal transduction. In addition to the IL-11-induced tyrosine phosphorylation of Syp, Syp coprecipitated with gp130, JAK2, and other tyrosine-phosphorylated proteins in response to IL-11. These findings may have extensive significance to IL-11 and related cytokine signal transduction, suggesting new pathways and mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559603     DOI: 10.1074/jbc.270.42.24826

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development.

Authors:  C K Qu; Z Q Shi; R Shen; F Y Tsai; S H Orkin; G S Feng
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity.

Authors:  Z Q Shi; D H Yu; M Park; M Marshall; G S Feng
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Dual signaling role of the protein tyrosine phosphatase SHP-2 in regulating expression of acute-phase plasma proteins by interleukin-6 cytokine receptors in hepatic cells.

Authors:  H Kim; H Baumann
Journal:  Mol Cell Biol       Date:  1999-08       Impact factor: 4.272

4.  The transcription co-repressor TLE1 interacted with the intracellular region of gpl30 through its Q domain.

Authors:  Fei Liu; Yin Liu; Demin Li; Yong Zhu; Weiming Ouyang; Xin Xie; Boquan Jin
Journal:  Mol Cell Biochem       Date:  2002-03       Impact factor: 3.396

Review 5.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

6.  Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.

Authors:  F Schaper; C Gendo; M Eck; J Schmitz; C Grimm; D Anhuf; I M Kerr; P C Heinrich
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.

Authors:  Mary Arnaud; Rym Mzali; Franck Gesbert; Catherine Crouin; Christine Guenzi; Claudine Vermot-Desroches; John Wijdenes; Geneviève Courtois; Olivier Bernard; Jacques Bertoglio
Journal:  Biochem J       Date:  2004-09-01       Impact factor: 3.857

8.  Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways.

Authors:  T K Sengupta; E M Schmitt; L B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation.

Authors:  K Rajagopal; C L Sommers; D C Decker; E O Mitchell; U Korthauer; A I Sperling; C A Kozak; P E Love; J A Bluestone
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.